Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on Sales

Sotera Health (SHC) EBIT Margin (2020 - 2025)

Historic EBIT Margin for Sotera Health (SHC) over the last 6 years, with Q3 2025 value amounting to 36.7%.

  • Sotera Health's EBIT Margin rose 85000.0% to 36.7% in Q3 2025 from the same period last year, while for Sep 2025 it was 32.29%, marking a year-over-year increase of 42300.0%. This contributed to the annual value of 27.05% for FY2024, which is 6800.0% up from last year.
  • Per Sotera Health's latest filing, its EBIT Margin stood at 36.7% for Q3 2025, which was up 85000.0% from 33.2% recorded in Q2 2025.
  • Sotera Health's 5-year EBIT Margin high stood at 36.7% for Q3 2025, and its period low was 15.13% during Q1 2023.
  • Over the past 5 years, Sotera Health's median EBIT Margin value was 27.77% (recorded in 2024), while the average stood at 27.17%.
  • Within the past 5 years, the most significant YoY rise in Sotera Health's EBIT Margin was 96200bps (2023), while the steepest drop was -74700bps (2023).
  • Over the past 5 years, Sotera Health's EBIT Margin (Quarter) stood at 27.53% in 2021, then dropped by -13bps to 23.92% in 2022, then surged by 40bps to 33.53% in 2023, then dropped by -10bps to 30.03% in 2024, then rose by 22bps to 36.7% in 2025.
  • Its EBIT Margin was 36.7% in Q3 2025, compared to 33.2% in Q2 2025 and 28.43% in Q1 2025.